患有性结肠炎的年轻肝移植患者扩散性大B细胞淋巴瘤的诊断挑战:一个病例报告
Maria Kopoń1, Aleksandra Wileńska1,2, Marek Zdrenka3
1Gastroenterology Clinic, Jan Biziel University No. 2, Bydgoszcz, Poland.
The American journal of case reports
|September 26, 2025
概括
这一案例突出了一个年轻的肝移植患者,他患有与爱斯坦-巴尔病毒 (EBV) 和免疫抑制相关的扩散性大B细胞淋巴瘤 (DLBCL). 在接受免疫抑制治疗的患者中,早期查EBV至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的恶性淋巴瘤.
- 与年龄相关的免疫力下降和爱斯坦-巴尔病毒 (EBV) 与淋巴瘤的发展有关.
- 本报告侧重于DLBCL的一个独特病例,该病例发生在患有性结肠炎 (UC) 的年轻肝移植接受者身上.
研究的目的:
- 描述一个罕见的DLBCL病例在一个年轻的,免疫抑制患者.
- 强调诊断挑战和EBV和免疫抑制在瘤发生过程中的作用.
- 倡导在免疫抑制治疗前强制进行EBV查.
主要方法:
- 一个22岁的患者的病例报告,患有UC,肝移植和免疫抑制药物使用.
- 最初的呈现与阴茎状症状,导致延迟DLBCL诊断.
- 诊断工作包括X射线,EBV血清学,CT扫描和皮肤淋巴结活检.
主要成果:
- 这位患者被诊断为DLBCL.
- EBV血清学是阳性的 (IgG类).
- 患者在6轮R-CHOP化疗后实现了缓解.
结论:
- 临床医生必须考虑EBV感染的长期免疫抑制患者的瘤发生风险.
- 建议在免疫抑制治疗之前强制进行EBV查.
- 密切监测瘤风险对于接受免疫抑制治疗的EBV阳性患者至关重要.
更多相关视频
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
440
09:48Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
Published on: September 26, 2019
16.6K
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
903
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
903
Chronic Bowel Disorders: Introduction
747
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
747
Drugs for Treatment of Ulcerative Colitis in IBD
460
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
460
Diseases of the Liver and Gallbladder
1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
